Galderma announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company?s Injectable ...
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the ...
Dallas developer KDC plans about $3.5B in credit-tenant lease financing to fund AT&T's 54-acre Plano HQ; loan life ~18.7 ...
Operator: Greetings, and welcome to the Third Coast Bancshares Third Quarter Earnings Conference Call. [Operator Instructions ...
If reading Colorado's ballot measures makes you feel like you need to go back to school, join the club. The big picture: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results